NCT00311636 - Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | Biotech Hunter

Enrollment

280

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

January 31, 2008

Study Completion Date

April 30, 2008

Conditions

Breast Cancer

Interventions

DRUG

cyclophosphamide

DRUG

docetaxel

DRUG

doxorubicin hydrochloride

DRUG

epirubicin hydrochloride

DRUG

fluorouracil

DRUG

methotrexate

DRUG

paclitaxel

DRUG

triptorelin

PROCEDURE

adjuvant therapy

Trial Locations (18)

10126

Universita di Torino, Turin

12100

Ospedale Santa Croce, Cuneo

16132

Istituto Nazionale per la Ricerca sul Cancro, Genoa

22100

Ospedale Sant Anna, Como

24047

Ospedale Treviglio Caravaggio, Treviglio

31033

Ospedale Civile, Castelfranco - TV

34100

Ospedale Maggiore dell' Universita, Trieste

46100

Carlo Poma Hospital, Mantova

50011

Azienda Ospedaliera di Firenze, Florence

56126

Ospedale Santa Chiara Pisa, Pisa

57100

Presidio Ospedaliero di Livorno, Livorno

80131

Federico II University Medical School, Naples

Seconda Universita di Napoli, Naples

81131

Istituto G. Pascale, Naples

06156

Ospedale Silvestrini, Perugia

00128

Istituto Regina Elena, Rome

07100

Ospedale Civile ASL 1, Sassari

03039

Ospedale SS Trinita, Sora

All Listed Sponsors

lead

Gruppo Italiano Mammella (GIM)

OTHER